Outcome definitions and predictors in depression

Psychotherapy and Psychosomatics

Volumn 67, Issue 4-5, 1998, Pages 266-270

  Tedlow, Joyce ^a   Fava, Maurizio ^b   Uebelacker, Lisa ^b   Nierenberg, Andrew A ^b   Alpert, Jonathan E ^b   Rosenbaum, Jerrold ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Depression; Fluoxetine

Indexed keywords

FLUOXETINE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; REGRESSION ANALYSIS;

EID: 0031927558     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012290     Document Type: Article

References (28)

1. Bielski R, Friedel R: Prediction of tricyclic antidepressant response: A critical review. Arch Gen Psychiatry 1976;33:1479-1489.
2. Prusoff BA, Weissman MM, Klerman GL, Rousanville BJ: Research diagnostic criteria subtypes of depression. Arch Gen Psychiatry 1980;37:796-801.
3. Coppen A, Millin P, Harwood J, Wood K: Does the dexamethasone suppression test predict antidepressant treatment success? Br J Psychiatry 1985;146:294-296.
4. Scott J, Eccleston D: Prediction, treatment, and prognosis of chronic primary major depression. Int Clin Psychopharmacol 1991; 6(suppl 1):41-49.
5. Joyce PR, Paykel ES: Predictors of drug response in depression. Arch Gen Psychiatry 1989;46:89-99.
6. Association AP: The dexamethasone suppression test: An overview of its current status in psychiatry. Am J Psychiatry 1987;144:1253-1262.
7. Heiligenstein JH, Tollefson GD, Faries DE: Response patterns of depressed outpatients with and without melancholia: A double-blind placebo-controlled trial of fluoxetine versus placebo. J Affect Disord 1994;30:163-173.
8. Nelson JC, Mazure CM, Jatlow PI: Does melancholia predict response in major depression? J Affect Disord 1990;18:157-165.
9. Peselow ED, Sanfilipo MP, Defiglia C, Fieve RR: Melancholia/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 1992;149:1324-1334.
10. Davidson J, Turnbull C: Isocarboxazid: Efficacy and tolerance. J Affect Disord 1983;6:183-189.
11. Katz MM, Koslow SH, Maas JW, Frazer A, Bowden CL, Casper R, Croughan J, Kocsis J, Redmond E: The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 1987;17:297-309.
12. Hoencamp E, Haffmans PMJ, Duivenvoorden H, Knegtering H, Dijken WA: Predictors of (non-)response in depressed outpatients treated with a three-phase sequential medication strategy. J Affect Disord 1994;31:235-246.
13. Kocsis JH: Predicting treatment response in clinical psychopharmacology. Psychopharmacol Bull 1990;261:49-53.
14. Prien RF, Carpenter LL, Kupfer DJ: The definition and operational criteria for treatment outcome of major depressive disorder. Arch Gen Psychiatry 1991;48:796-800.
15. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
16. Joffe R, Bagby M, Levitt A: Anxious and non-anxious depression. Am J Psychiatry 1993;150: 1257-1258.
17. Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF: Major depressive subtypes and treatment response. Biol Psychiatry 1997;42:568-576.
18. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Edition (SCID-P, 9/1/89 version). New York, Biometrics Research Department, New York State Psychiatric Institute, 1989.
19. Guy W: ECDEU Assessment Manual for Psychopharmacology. DHEW Publ No (ADM) 76-338. Rockville, NIMH, 1976.
20. Tedlow JR, Fava M, Uebelacker LA, Alpert JA, Nierenberg AA, Rosenbaum JF: Are study dropouts different from completers? Biol Psychiatry 1996;40:668-670.
21. Kellner RA: Symptom Questionnaire. J Clin Psychiatry 1987;48:268-274.
22. Laird NM: Estimating rates of change in clinical studies; in Fava M, Rosenbaum JF (eds): Research Designs and Methods in Psychiatry. New York, Elsevier, 1992, vol 9, pp 185-194.
23. Angst J, Delini-Stula A, Stabl M, Stassen HH: Is a cut-off score a suitable measure of treatment outcome in short-term trials in depression? A methodological meta-analysis. Hum Psychopharmacol 1993;8:311-317.
24. Coryell W, Zimmerman M: Outcome following ECT for primary unipolar depression: A test of newly proposed predictors. Am J Psychiatry 1984;141:862-867.
25. Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ: Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996;16:3-8.
26. Fava GA: The concept of recovery in affective disorders. Psychother Psychosom 1996;65:2-13.
27. Ryff CD, Singer B: Psychological well-being. Psychother Psychosom 1996;65:14-23.
28. Bech P, Gudex C, Staehr Johansen K: The WHO (ten) well-being index. Psychother Psychosom 1996;65:183-190.